-
Short Interest In Baxter International And Celator Pharmaceuticals Doubles
Thursday, May 12, 2016 - 8:52am | 747Read More...Short interest in a number of stocks surged in the most recent settlement period. Two healthcare stocks were among those leading that trend in the final weeks of April. Shares of both rose in the period, but only one held on to that gain. With the markets surging last month and the S&P 500...
-
LifeTech Capital Maintains Strong Speculative Buy on StemCells (STEM)
Monday, March 14, 2011 - 8:35am | 106Read More...LifeTech Capital is out with its report today on StemCells (NASDAQ: STEM), maintaining Strong Speculative Buy. In a note sent to clients, LifeTech Capital writes, "We are maintaining a Strong Speculative Buy recommendation and Price Target of $2.20: We believe StemCells Inc. is one of the most...
